Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Pinheiro EM"'
Publikováno v:
Revista Latino-Americana de Enfermagem (RLAE). nov/dez2008, Vol. 16 Issue 6, p1012-1018. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Georgiev P; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Muise ES; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Linn DE; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Hinton MC; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Wang Y; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Cai M; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Cadzow L; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Wilson DC; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Sukumar S; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Caniga M; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Chen L; Department of Informatics IT, Merck & Co., Inc., Kenilworth, New Jersey., Xiao H; Department of Informatics IT, Merck & Co., Inc., Kenilworth, New Jersey., Yearley JH; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Sriram V; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Nebozhyn M; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Sathe M; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Blumenschein WM; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Kerr KS; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Hirsch HA; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Javaid S; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Olow AK; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Moy LY; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., Chiang DY; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Loboda A; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Cristescu R; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Sadekova S; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Long BJ; Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey., McClanahan TK; Department of Genome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey., Pinheiro EM; Department of Discovery Oncology, Merck & Co., Inc., Kenilworth, New Jersey.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2022 Mar 01; Vol. 21 (3), pp. 427-439.
Autor:
Raghavan S; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States.; Department of Microbiology and Immunology, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden., Tovbis-Shifrin N; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Kochel C; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Sawant A; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Mello M; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille Université (UMS3367), National Institute of Health and Medical Research (INSERM) (US012), The French National Centre for Scientific Research (CNRS) (UMS3367), Marseille, France., Sathe M; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Blumenschein W; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Muise ES; Merck & Co., Inc., Boston, MA, United States., Chackerian A; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Pinheiro EM; Merck & Co., Inc., Boston, MA, United States., Rosahl TW; Merck & Co., Inc., Kenilworth, NJ, United States., Luche H; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille Université (UMS3367), National Institute of Health and Medical Research (INSERM) (US012), The French National Centre for Scientific Research (CNRS) (UMS3367), Marseille, France., de Waal Malefyt R; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Nov 29; Vol. 12, pp. 752348. Date of Electronic Publication: 2021 Nov 29 (Print Publication: 2021).
Quasi-Experimental study of effects of lighting on rest, activity and melatonin in postpartum women.
Autor:
Volcov CF; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Pinheiro EM; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Tsunemi MH; Universidade Estadual Paulista Júlio de Mesquita Filho, Instituto de Biociências. Botucatu, São Paulo, Brazil., Amaral FGD; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Avelar AFM; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Hocking J; Australian Catholic University. Melbourne, Vitória, Australia., Coca KP; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil.
Publikováno v:
Revista brasileira de enfermagem [Rev Bras Enferm] 2021 Aug 13; Vol. 74 (6), pp. e20201064. Date of Electronic Publication: 2021 Aug 13 (Print Publication: 2021).
Autor:
Taylor MH; Earle A Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213, USA., Schmidt EV; Department of Clinical Oncology, Merck & Co. Inc., Kenilworth, NJ 07033, USA., Dutcus C; Department of Clinical Research, Eisai Inc., Woodcliff Lake, NJ 07677, USA., Pinheiro EM; Department of Clinical Oncology, Merck & Co. Inc., Kenilworth, NJ 07033, USA., Funahashi Y; Biomarker Research Translational Science Department, Eisai Co., Ltd., Tokyo, 112-0002, Japan., Lubiniecki G; Department of Clinical Oncology, Merck & Co. Inc., Kenilworth, NJ 07033, USA., Rasco D; The START Center for Cancer Care, San Antonio, TX 78229, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2021 Feb; Vol. 17 (6), pp. 637-648. Date of Electronic Publication: 2020 Dec 10.
Autor:
Sato MH; Federal University of São Paulo, Brazil., Pedreira MDLG; Federal University of São Paulo, Brazil.; National Council for Scientific and Technological Development, Sao Paulo, Brazil., Avelar AFM; Federal University of São Paulo, Brazil., Tsunemi MH; Universidade Estadual Paulista Júlio de Mesquita Filho, Sao Paulo, Brazil., Orsi KCSC; Federal University of São Paulo, Brazil., Pradella-Hallinan MLC; Associação Fundo de Incentivo à Pesquisa, Sao Paulo, Brazil., Avena MJ; Federal University of São Paulo, Brazil., Pinheiro EM; Federal University of São Paulo, Brazil.; Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil.
Publikováno v:
Clinical nursing research [Clin Nurs Res] 2020 May; Vol. 29 (4), pp. 260-267. Date of Electronic Publication: 2018 Oct 19.
Autor:
Oliveira AMF; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Andrade PR; Centro Assistencial Cruz de Malta. São Paulo, São Paulo, Brazil., Pinheiro EM; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Avelar AFM; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Costa P; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil., Belela-Anacleto ASC; Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil.
Publikováno v:
Revista brasileira de enfermagem [Rev Bras Enferm] 2020 Mar 30; Vol. 73 (2), pp. e20190458. Date of Electronic Publication: 2020 Mar 30 (Print Publication: 2020).
Autor:
Schmidt EV; Merck and Co, Inc, Kenilworth, New Jersey., Chisamore MJ; Merck and Co, Inc, Kenilworth, New Jersey., Chaney MF; Merck and Co, Inc, Kenilworth, New Jersey., Maradeo ME; Merck and Co, Inc, Kenilworth, New Jersey., Anderson J; Merck and Co, Inc, Kenilworth, New Jersey., Baltus GA; Merck and Co, Inc, Kenilworth, New Jersey., Pinheiro EM; Merck and Co, Inc, Kenilworth, New Jersey., Uebele VN; Merck and Co, Inc, Kenilworth, New Jersey.
Publikováno v:
JAMA network open [JAMA Netw Open] 2020 Feb 05; Vol. 3 (2), pp. e1920833. Date of Electronic Publication: 2020 Feb 05.